| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6033120 | NeuroImage | 2012 | 11 Pages |
Abstract
⺠Glutamate receptor agonists increase MEMRI signal in the hypothalamus and hippocampus. ⺠Glutamate induced increase in MEMRI signal is blocked by AMPA receptor antagonist. ⺠An NMDA receptor antagonist decreases MEMRI signal in the hypothalamus. ⺠High dose monosodium glutamate increases MEMRI signal in the subarachnoid region.
Keywords
(5R,10S)-(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine(ROI)(i.p.)manganese enhanced MRI2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dionePerfusion weighted imagingintraperitonealIntravenousblood brain barriersignal intensityNeuronal activityblood-CSF barriermedian eminenceregion of interestVentromedial nucleusarcuate nucleusparaventricular nucleusSuprachiasmatic nucleusgonadotrophin releasing hormoneHypothalamusglutamatemonosodium glutamateMetabotropic glutamate receptorionotropic glutamate receptor
Related Topics
Life Sciences
Neuroscience
Cognitive Neuroscience
Authors
Mohammed K. Hankir, James R. Parkinson, Stephen R. Bloom, Jimmy D. Bell,